Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9100
Title: Unenhanced and contrast-enhanced MR angiography and perfusion imaging for suspected pulmonary thromboembolism
Authors: Ohno, Y.
Yoshikawa, T.
Kishida, Y.
Seki, S.
Karabulut, Nevzat
Keywords: CT
Deep venous thrombosis
MR angiography
MRI
Pulmonary thromboembolism
gadolinium pentetate
contrast medium
arterial spin labeling
computed tomographic angiography
contrast enhancement
deep vein thrombosis
diagnostic accuracy
diagnostic value
digital subtraction angiography
dynamic first pass contrast enhanced perfusion magnetic resonance imaging
echography
human
intermethod comparison
lung embolism
magnetic resonance angiography
magnetic resonance venography
multidetector computed tomography
nuclear magnetic resonance scanner
perfusion weighted imaging
phlebography
predictive value
reliability
Review
sensitivity and specificity
single photon emission computed tomography
three dimensional imaging
time resolved contrast enhanced magnetic resonance angiography
diagnostic imaging
differential diagnosis
image enhancement
procedures
reproducibility
vein thrombosis
Contrast Media
Diagnosis, Differential
Humans
Image Enhancement
Magnetic Resonance Angiography
Phlebography
Pulmonary Embolism
Reproducibility of Results
Sensitivity and Specificity
Venous Thrombosis
Publisher: American Roentgen Ray Society
Abstract: OBJECTIVE. This article discusses the basics of unenhanced MR angiography (MRA) and MR venography (MRV), time-resolved contrast-enhanced (CE) MRA and dynamic firstpass CE perfusion MRI, and unenhanced and CE MRV, in addition to assessing the clinical relevance of these techniques for evaluating patients with suspected pulmonary thromboembolism and deep venous thrombosis. CONCLUSION. Since the 1990s, the efficacy of MRA or MRV and dynamic perfusion MRI for patients with suspected pulmonary thromboembolism and deep venous thrombosis has been evaluated. On the basis of the results of single-center trials, comprehensive MRI protocols, including pulmonary unenhanced and CE MRA, perfusion MRI, and MRV, promise to be safe and time effective for assessing patients with suspected pulmonary thromboembolism, although future multicenter trials are required to assess the real clinical value of MRI. © 2017 American Roentgen Ray Society.
URI: https://hdl.handle.net/11499/9100
https://doi.org/10.2214/AJR.16.17415
ISSN: 0361-803X
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

19
checked on Dec 21, 2024

WEB OF SCIENCETM
Citations

19
checked on Dec 19, 2024

Page view(s)

32
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.